HomeSLP • NASDAQ
Simulations Plus Inc
add
$35.21
0.82%
After Hours:(0.00%)0.00
$35.21
Closed: Apr 28, 4:02:15 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | 22.43M | 22.55% |
Operating expense | 10.42M | 18.64% |
Net income | 3.07M | -23.70% |
Net profit margin | 13.70 | -37.76% |
Earnings per share | 0.31 | 55.00% |
EBITDA | 4.19M | -18.67% |
Effective tax rate | 12.37% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.39M | -80.29% |
Total assets | 201.43M | 3.84% |
Total liabilities | 11.88M | -29.86% |
Total equity | 189.55M | — |
Shares outstanding | 20.11M | — |
Price to book | 3.76 | — |
Return on assets | 3.40% | — |
Return on capital | 3.60% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | 3.07M | -23.70% |
Cash from operations | 5.67M | -2.43% |
Cash from investing | 684.00K | 109.10% |
Cash from financing | -1.55M | -47.15% |
Net change in cash | 4.81M | 274.22% |
Free cash flow | 2.71M | -56.52% |
Previous close
$35.50
Day range
$34.35 - $36.00
Year range
$23.01 - $51.22
Market cap
708.11M USD
Avg Volume
387.05K
P/E ratio
98.64
Dividend yield
0.68%
Primary exchange
NASDAQ
About
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services. Wikipedia
Founded
1996
Headquarters
Website
Employees
245
